News & Updates

Show Multimedia Only

Focal therapy an effective option for older, comorbid prostate cancer patients

02 Jul 2023

Focal ablative therapy may be used as an alternative treatment for older or comorbid patients with prostate cancer who are not fit or willing to undergo radical treatment, suggests a study.

Focal therapy an effective option for older, comorbid prostate cancer patients

02 Jul 2023

History of child abuse linked to female sexual dysfunction in midlife

01 Jul 2023

Women w an adverse childhood experience (ACE) are more likely to experience sexual dysfunction (SD) and sexual inactivity in midlife, irrespective of other factors that may influence female sexual function in adulthood, reveals a study.

History of child abuse linked to female sexual dysfunction in midlife

01 Jul 2023

COVID outcomes worse in polluted cities

01 Jul 2023 by

More evidence suggests that people exposed to more air pollution during the pandemic are at greater risk for COVID-19 infection, hospitalization, and death, but the exact mechanism behind the link is unknown.

COVID outcomes worse in polluted cities

01 Jul 2023

Heparin unable to prevent miscarriages in women with inherited thrombophilia

01 Jul 2023 by

Daily shots of low-molecular weight heparin (LMWH) fall short of improving live birth rates for women with a history of at least two pregnancy losses and inherited thrombophilia, according to the results of the open-label trial ALIFE2.

Heparin unable to prevent miscarriages in women with inherited thrombophilia

01 Jul 2023

Early menopause, premature ovarian insufficiency spell increased dementia risk

01 Jul 2023

Early menopause or premature ovarian insufficiency may put women at increased risk of dementia, as reported in a recent study.

Early menopause, premature ovarian insufficiency spell increased dementia risk

01 Jul 2023

Original New Drug Application Approvals by US FDA (16-30 June 2023)

01 Jul 2023

New drug applications approved by US FDA as of 16-30 June 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 June 2023)

01 Jul 2023

Heavy coffee drinking may increase abdominal aortic calcification for some

30 Jun 2023

Adults with hypertension, diabetes, and cardiovascular diseases may benefit from cutting back on coffee, especially the caffeinated variant, which has been shown to increase the burden of abdominal aortic calcification in a study.

Heavy coffee drinking may increase abdominal aortic calcification for some

30 Jun 2023

Another IBAT inhibitor makes its case in large PFIC trial

30 Jun 2023 by

The ileal bile acid transporter (IBAT) inhibitor maralixibat appears to quell itching and reduce serum bile acid concentration in children with progressive familial intrahepatic cholestasis (PFIC), while having a tolerable safety profile, according to data from the phase III MARCH-PFIC trial said to be the largest to date.

Another IBAT inhibitor makes its case in large PFIC trial

30 Jun 2023

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

30 Jun 2023

Implementation of the mandate on preablation renal mass biopsy appears to result in the wider use of biopsies for all small renal mass patients, fewer surgical interventions, and an increase in active surveillance, reports a recent study.

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

30 Jun 2023

Pembrolizumab plus gemcitabine/cisplatin improves survival in metastatic biliary tract cancer

30 Jun 2023 by

Treatment with pembrolizumab (pembro) in combination with gemcitabine and cisplatin (gem/cis) results in a statistically significant, clinically meaningful improvement in overall survival (OS) when compared with placebo plus gem/cis in patients with previously untreated metastatic or unresectable biliary tract cancer (BTC), results of the KEYNOTE-966 study have shown.

Pembrolizumab plus gemcitabine/cisplatin improves survival in metastatic biliary tract cancer

30 Jun 2023

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Focal therapy an effective option for older, comorbid prostate cancer patients

Focal therapy an effective option for older, comorbid prostate cancer patients

History of child abuse linked to female sexual dysfunction in midlife

History of child abuse linked to female sexual dysfunction in midlife

COVID outcomes worse in polluted cities

COVID outcomes worse in polluted cities

Heparin unable to prevent miscarriages in women with inherited thrombophilia

Heparin unable to prevent miscarriages in women with inherited thrombophilia

Early menopause, premature ovarian insufficiency spell increased dementia risk

Early menopause, premature ovarian insufficiency spell increased dementia risk

Original New Drug Application Approvals by US FDA (16-30 June 2023)

Original New Drug Application Approvals by US FDA (16-30 June 2023)

Heavy coffee drinking may increase abdominal aortic calcification for some

Heavy coffee drinking may increase abdominal aortic calcification for some

Another IBAT inhibitor makes its case in large PFIC trial

Another IBAT inhibitor makes its case in large PFIC trial

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

Renal mass biopsy mandate tied to fewer surgeries, greater surveillance

Pembrolizumab plus gemcitabine/cisplatin improves survival in metastatic biliary tract cancer

Pembrolizumab plus gemcitabine/cisplatin improves survival in metastatic biliary tract cancer